A high-throughput detection method for the clonality of Human T-cell leukemia virus type-1-infected cells in vivo

[1]  A. Utsunomiya,et al.  The Nature of the HTLV-1 Provirus in Naturally Infected Individuals Analyzed by the Viral DNA-Capture-Seq Approach. , 2019, Cell reports.

[2]  John R. Garbe,et al.  EditR: A Method to Quantify Base Editing from Sanger Sequencing , 2018, The CRISPR journal.

[3]  M. Georges,et al.  Monitoring molecular response in adult T-cell leukemia by high-throughput sequencing analysis of HTLV-1 clonality , 2017, Leukemia.

[4]  Kenta Nakai,et al.  Clonality of HTLV-1-infected T cells as a risk indicator for development and progression of adult T-cell leukemia. , 2017, Blood advances.

[5]  Toshiki Watanabe.  Adult T-cell leukemia: molecular basis for clonal expansion and transformation of HTLV-1-infected T cells. , 2017, Blood.

[6]  M. Nakao,et al.  Application of targeted enrichment to next-generation sequencing of retroviruses integrated into the host human genome , 2016, Scientific Reports.

[7]  H. Aburatani,et al.  Integrated molecular analysis of adult T cell leukemia/lymphoma , 2015, Nature Genetics.

[8]  K. Sugamura,et al.  Identification of TL-Om1, an Adult T-Cell Leukemia (ATL) Cell Line, as Reference Material for Quantitative PCR for Human T-Lymphotropic Virus 1 , 2014, Journal of Clinical Microbiology.

[9]  Yosvany López,et al.  Development and validation of a new high-throughput method to investigate the clonality of HTLV-1-infected cells based on provirus integration sites , 2014, Genome Medicine.

[10]  F. Bushman,et al.  The host genomic environment of the provirus determines the abundance of HTLV-1–infected T-cell clones , 2011, Blood.

[11]  K. Yamaguchi,et al.  Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: a nationwide prospective study in Japan. , 2010, Blood.

[12]  Stephan Wolf,et al.  Genome-wide high-throughput integrome analyses by nrLAM-PCR and next-generation sequencing , 2010, Nature Protocols.

[13]  Luca Biasco,et al.  Comprehensive genomic access to vector integration in clinical gene therapy , 2009, Nature Medicine.

[14]  M. Matsuoka,et al.  Preferential selection of human T-cell leukemia virus type I provirus integration sites in leukemic versus carrier states. , 2005, Blood.

[15]  M. Matsuoka,et al.  Two types of defective human T-lymphotropic virus type I provirus in adult T-cell leukemia. , 1996, Blood.

[16]  T. Honjo,et al.  Origin of human T-lymphotrophic virus I-positive T cell lines in adult T cell leukemia. Analysis of T cell receptor gene rearrangement , 1985, The Journal of experimental medicine.